Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Within-host infectious disease models accommodating cellular coinfection, with an application to influenza.

Koelle K, Farrell AP, Brooke CB, Ke R.

Virus Evol. 2019 Jul 8;5(2):vez018. doi: 10.1093/ve/vez018. eCollection 2019 Jul. Erratum in: Virus Evol. 2019 Nov 19;5(2):vez052.

2.

What's New with Flu? An Overview.

Lakdawala SS, Brooke CB.

Viruses. 2019 May 10;11(5). pii: E433. doi: 10.3390/v11050433.

3.

Teaching an Old Virus New Tricks: A Review on New Approaches to Study Age-Old Questions in Influenza Biology.

Lakdawala SS, Lee N, Brooke CB.

J Mol Biol. 2019 Oct 4;431(21):4247-4258. doi: 10.1016/j.jmb.2019.04.038. Epub 2019 Apr 30. Review.

PMID:
31051174
4.

MORC3 Is a Target of the Influenza A Viral Protein NS1.

Zhang Y, Ahn J, Green KJ, Vann KR, Black J, Brooke CB, Kutateladze TG.

Structure. 2019 Jun 4;27(6):1029-1033.e3. doi: 10.1016/j.str.2019.03.015. Epub 2019 Apr 18.

PMID:
31006586
5.

Sequencing Framework for the Sensitive Detection and Precise Mapping of Defective Interfering Particle-Associated Deletions across Influenza A and B Viruses.

Alnaji FG, Holmes JR, Rendon G, Vera JC, Fields CJ, Martin BE, Brooke CB.

J Virol. 2019 May 15;93(11). pii: e00354-19. doi: 10.1128/JVI.00354-19. Print 2019 Jun 1.

6.

Prevotella copri, a potential indicator for high feed efficiency in western steers.

Brooke CG, Najafi N, Dykier KC, Hess M.

Anim Sci J. 2019 May;90(5):696-701. doi: 10.1111/asj.13197. Epub 2019 Mar 7.

PMID:
30848016
7.

A 2.08 Å resolution structure of HLB5, a novel cellulase from the anaerobic gut bacterium Parabacteroides johnsonii DSM 18315.

Chang C, Brooke C, Piao H, Mack J, Babnigg G, Joachimiak A, Hess M.

Protein Sci. 2019 Apr;28(4):794-799. doi: 10.1002/pro.3582. Epub 2019 Feb 18.

8.

Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies.

Kosik I, Angeletti D, Gibbs JS, Angel M, Takeda K, Kosikova M, Nair V, Hickman HD, Xie H, Brooke CB, Yewdell JW.

J Exp Med. 2019 Feb 4;216(2):304-316. doi: 10.1084/jem.20181624. Epub 2019 Jan 25.

9.

Flu Shows the Power of Diversity.

Martin BE, Brooke CB.

Cell. 2019 Jan 10;176(1-2):9-10. doi: 10.1016/j.cell.2018.12.017.

10.

Causes and Consequences of Spatial Within-Host Viral Spread.

Gallagher ME, Brooke CB, Ke R, Koelle K.

Viruses. 2018 Nov 13;10(11). pii: E627. doi: 10.3390/v10110627. Review.

11.

Influenza A Virus Superinfection Potential Is Regulated by Viral Genomic Heterogeneity.

Sun J, Brooke CB.

mBio. 2018 Oct 30;9(5). pii: e01761-18. doi: 10.1128/mBio.01761-18.

12.

The parts are greater than the whole: the role of semi-infectious particles in influenza A virus biology.

Diefenbacher M, Sun J, Brooke CB.

Curr Opin Virol. 2018 Dec;33:42-46. doi: 10.1016/j.coviro.2018.07.002. Epub 2018 Jul 24. Review.

13.

Charge transport at a molecular GaAs nanoscale junction.

Vezzoli A, Brooke RJ, Ferri N, Brooke C, Higgins SJ, Schwarzacher W, Nichols RJ.

Faraday Discuss. 2018 Oct 1;210(0):397-408. doi: 10.1039/c8fd00016f.

PMID:
29978881
14.

Correction: Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs.

Kosik I, Ince WL, Gentles LE, Oler AJ, Kosikova M, Angel M, Magadán JG, Xie H, Brooke CB, Yewdell JW.

PLoS Pathog. 2018 Jun 20;14(6):e1007141. doi: 10.1371/journal.ppat.1007141. eCollection 2018 Jun.

15.

Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs.

Kosik I, Ince WL, Gentles LE, Oler AJ, Kosikova M, Angel M, Magadán JG, Xie H, Brooke CB, Yewdell JW.

PLoS Pathog. 2018 Jan 18;14(1):e1006796. doi: 10.1371/journal.ppat.1006796. eCollection 2018 Jan. Erratum in: PLoS Pathog. 2018 Jun 20;14(6):e1007141.

16.

Population Diversity and Collective Interactions during Influenza Virus Infection.

Brooke CB.

J Virol. 2017 Oct 27;91(22). pii: e01164-17. doi: 10.1128/JVI.01164-17. Print 2017 Nov 15. Review.

17.

Using "Policy Briefs" to Present Scientific Results of CBPR: Farmworkers in North Carolina.

Arcury TA, Wiggins MF, Brooke C, Jensen A, Summers P, Mora DC, Quandt SA.

Prog Community Health Partnersh. 2017;11(2):137-147. doi: 10.1353/cpr.2017.0018.

19.

Gating of single molecule junction conductance by charge transfer complex formation.

Vezzoli A, Grace I, Brooke C, Wang K, Lambert CJ, Xu B, Nichols RJ, Higgins SJ.

Nanoscale. 2015 Dec 7;7(45):18949-55. doi: 10.1039/c5nr04420k. Epub 2015 Oct 29.

PMID:
26510687
20.

Farmworker Housing in the United States and Its Impact on Health.

Quandt SA, Brooke C, Fagan K, Howe A, Thornburg TK, McCurdy SA.

New Solut. 2015 Nov;25(3):263-86. doi: 10.1177/1048291115601053. Epub 2015 Aug 28. Review.

PMID:
26320122
21.

Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility.

Brooke CB, Ince WL, Wei J, Bennink JR, Yewdell JW.

Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16854-9. doi: 10.1073/pnas.1415396111. Epub 2014 Nov 10.

22.
23.

The synthesis and structure of chiral enamine N-oxides.

O'Neil IA, McConville M, Zhou K, Brooke C, Robertson CM, Berry NG.

Chem Commun (Camb). 2014 Jul 14;50(55):7336-9. doi: 10.1039/c3cc47928e.

PMID:
24869947
24.

Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection.

Das SR, Hensley SE, Ince WL, Brooke CB, Subba A, Delboy MG, Russ G, Gibbs JS, Bennink JR, Yewdell JW.

Cell Host Microbe. 2013 Mar 13;13(3):314-23. doi: 10.1016/j.chom.2013.02.008.

25.

Host versus flu: antibodies win a round?

Brooke CB, Yewdell JW.

Nat Struct Mol Biol. 2013 Mar;20(3):245-6. doi: 10.1038/nsmb.2524. No abstract available.

26.

Most influenza a virions fail to express at least one essential viral protein.

Brooke CB, Ince WL, Wrammert J, Ahmed R, Wilson PC, Bennink JR, Yewdell JW.

J Virol. 2013 Mar;87(6):3155-62. doi: 10.1128/JVI.02284-12. Epub 2013 Jan 2. Erratum in: J Virol. 2013 Jul;87(14):8267.

27.

Photocatalysis of chloroform decomposition by the hexachlororuthenate(IV) ion.

Chan AM, Peña LA, Segura RE, Auroprem R, Harvey BM, Brooke CM, Hoggard PE.

Photochem Photobiol. 2013 Mar-Apr;89(2):274-9. doi: 10.1111/php.12005. Epub 2012 Nov 8.

PMID:
23050803
28.

Clinical procurement specialist: a personal perspective.

Brooke C.

J Perioper Pract. 2012 May;22(5):suppl 4-5. No abstract available.

PMID:
22720506
29.

Monocytes, viruses and metaphors: hanging the Trojan horse.

Yewdell JW, Brooke CB.

Cell Cycle. 2012 May 1;11(9):1748-9. doi: 10.4161/cc.20311. Epub 2012 May 1. No abstract available.

30.

Viral infection triggers rapid differentiation of human blood monocytes into dendritic cells.

Hou W, Gibbs JS, Lu X, Brooke CB, Roy D, Modlin RL, Bennink JR, Yewdell JW.

Blood. 2012 Mar 29;119(13):3128-31. doi: 10.1182/blood-2011-09-379479. Epub 2012 Feb 6.

31.

Early activation of the host complement system is required to restrict central nervous system invasion and limit neuropathology during Venezuelan equine encephalitis virus infection.

Brooke CB, Schäfer A, Matsushima GK, White LJ, Johnston RE.

J Gen Virol. 2012 Apr;93(Pt 4):797-806. doi: 10.1099/vir.0.038281-0. Epub 2011 Dec 28.

32.

The role of the blood-brain barrier during Venezuelan equine encephalitis virus infection.

Schäfer A, Brooke CB, Whitmore AC, Johnston RE.

J Virol. 2011 Oct;85(20):10682-90. doi: 10.1128/JVI.05032-11. Epub 2011 Aug 17.

33.

T cells facilitate recovery from Venezuelan equine encephalitis virus-induced encephalomyelitis in the absence of antibody.

Brooke CB, Deming DJ, Whitmore AC, White LJ, Johnston RE.

J Virol. 2010 May;84(9):4556-68. doi: 10.1128/JVI.02545-09. Epub 2010 Feb 24.

34.

Conservation and adaptation to climate change.

Brooke C.

Conserv Biol. 2008 Dec;22(6):1471-6. doi: 10.1111/j.1523-1739.2008.01031.x. Epub 2008 Aug 28.

PMID:
18759775
35.

Raman spectroscopic analysis of the enigmatic Comper pigments.

Edwards HG, Wolstenholme R, Wilkinson DS, Brooke C, Pepper M.

Anal Bioanal Chem. 2007 Mar;387(6):2255-62. Epub 2007 Jan 23.

PMID:
17242886
37.

Raman spectroscopic study of a post-medieval wall painting in need of conservation.

Edwards HG, Farwell DW, Brooke CJ.

Anal Bioanal Chem. 2005 Sep;383(2):312-21. Epub 2005 Oct 12.

PMID:
16132151
38.

Prevalence, risk factors and molecular epidemiology of Brachyspira pilosicoli in humans on the island of Bali, Indonesia.

Margawani KR, Robertson ID, Brooke CJ, Hampson DJ.

J Med Microbiol. 2004 Apr;53(Pt 4):325-332. doi: 10.1099/jmm.0.05415-0.

PMID:
15017290
39.

In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans.

Brooke CJ, Hampson DJ, Riley TV.

Antimicrob Agents Chemother. 2003 Jul;47(7):2354-7.

40.

Evaluation of selective media for the isolation of Brachyspira aalborgi from human faeces.

Brooke CJ, Riley TV, Hampson DJ.

J Med Microbiol. 2003 Jun;52(Pt 6):509-513. doi: 10.1099/jmm.0.05105-0.

PMID:
12748271
41.

Failure to detect Brachyspira pilosicoli in bloodstream of Australian patients.

Brooke CJ, Hampson DJ, Riley TV, Lum G.

J Clin Microbiol. 2001 Nov;39(11):4219. No abstract available.

42.

PCR detection of Brachyspira aalborgi and Brachyspira pilosicoli in human faeces.

Mikosza AS, La T, Margawani KR, Brooke CJ, Hampson DJ.

FEMS Microbiol Lett. 2001 Apr 13;197(2):167-70.

43.

Evaluation of blood culture systems for detection of the intestinal spirochaete Brachyspira (Serpulina) pilosicoli in human blood.

Brooke CJ, Margawani KR, Pearson AK, Riley TV, Robertson ID, Hampson DJ.

J Med Microbiol. 2000 Nov;49(11):1031-1036. doi: 10.1099/0022-1317-49-11-1031.

PMID:
11073157
44.

Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen.

Brooke CJ, Riley TV.

J Med Microbiol. 1999 Sep;48(9):789-799. doi: 10.1099/00222615-48-9-789. Review.

PMID:
10482289
45.

PCR amplification from fixed tissue indicates frequent involvement of Brachyspira aalborgi in human intestinal spirochetosis.

Mikosza AS, La T, Brooke CJ, Lindboe CF, Ward PB, Heine RG, Guccion JG, de Boer WB, Hampson DJ.

J Clin Microbiol. 1999 Jun;37(6):2093-8.

46.

An investigation of "crayfish poisoning" in Western Australia.

Brooke CJ, McLaughlin V, Mee BJ, Riley TV.

Med J Aust. 1999 Mar 15;170(6):288. No abstract available.

PMID:
10212662
48.

The effect of low-dose bupivacaine on postoperative epidural fentanyl analgesia and thrombelastography.

Benzon HT, Wong CA, Wong HY, Brooke C, Wade L.

Anesth Analg. 1994 Nov;79(5):911-7.

PMID:
7978409
49.

Genomic structure and promoter activity of the human testis lactate dehydrogenase gene.

Cooker LA, Brooke CD, Kumari M, Hofmann MC, Millán JL, Goldberg E.

Biol Reprod. 1993 Jun;48(6):1309-19.

PMID:
8318584
50.

Noninflammatory bullae associated with epsilon-aminocaproic acid infusion.

Brooke CP, Spiers EM, Omura EF.

J Am Acad Dermatol. 1992 Nov;27(5 Pt 2):880-2.

PMID:
1469150

Supplemental Content

Loading ...
Support Center